comprehensive -WSS

comprehensive

author：comprehensive 2025-10-02 06:02:24 - browse：626

Illustration of a laptop on top of a TV with a hand sticking out, holding a newspaper. -- coverage from STAT — Adobe

WASHINGTON – If you live in this city, you’re probably awash in pharmacy benefit manager ads — whether you’re listening to an NPR podcast, reading the New York Times, streaming “Yellowstone,” or watching the U.S. Open Golf Championships. It doesn’t matter if it’s 5 a.m., primetime, or 11 p.m.; in between ads for dog joint supplements and the “Barbie” movie, you will inevitably learn about these middlemen of the prescription drug market.

Ads eviscerating and glorifying PBMs have been around for years. But they’ve intensified over the past three months as Congress scrutinizes PBMs’ role in shaping high drug prices. Over a half-dozen U.S. House and Senate Committees have started investigating PBMs, advancing bipartisan legislation to increase transparency in the industry; ban PBMs from charging more for a drug than what they pay (and pocketing the difference); and require them to pass all fees, rebates, and other payments they receive to insurers.

Lobbying groups have responded to this legislative push with dueling campaigns in the court of public opinion. On one side is the Pharmaceutical Care Management Association, the trade association representing PBMs, which argues that pharmaceutical companies are responsible for high drug prices. On the other side is the industry group PhRMA, which points the finger right back, saying that PBMs are really to blame. Both trade associations have launched ad campaigns worth millions of dollars, blanketing TV, radio, social media, print, and beyond.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Physician assistants need a new name. Here's what it should be

WSS

How artificial intelligence is being used to detect, treat cancer

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Court strikes down limits on filming of police in Arizona

Arena BioWorks launches in Cambridge to speed drug discovery

Nonprofit, backed by Microsoft, to certify AI tools in health care

Hospital chaplains balance Covid safety with patients’ spiritual needs

entertainment

comprehensive

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

How artificial intelligence is being used to detect, treat cancer

Tori Bowie and the unacceptable rates of Black maternal death

JPM pitch from hospitals? Revenue streams outside of patient care

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Organ transplantation is at a crossroads. Major reform is needed

State Dept. review finds Biden bears some blame for Afghanistan failures

Why an extreme heat and wildfire smoke combination can be so dangerous

What does generative AI mean for health care? We asked experts

Marvel Studios reveals new trailer for 'The Marvels': Watch here

explore

Caitlin Bernard's story shows physicians can't shy from advocacy

Does Paxlovid work in people vaccinated against Covid

FDA official pushes for dedicated emerging pathogens team

Profiling embryos to choose those with higher IQs is almost a reality

Why an extreme heat and wildfire smoke combination can be so dangerous

Male doctors called my cancer incurable. A female doctor showed it wasn't

knowledge

hotspot

knowledge

focus